New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Icon acquires HumanFirst to boost support for digital tools in clinical trials

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research

February 29, 2024

All-cause thyrotoxicosis associated with increased risk of cognitive disorders

Thyrotoxicosis -; excess thyroid hormone levels in the body -; has been linked to an increased risk of cognitive disorders among older adults, according to

November 28, 2023

Laboring in 90 Degrees, Indoors: Workers Push for Action on Heat-Related Illness

As the nation continues to fry in this summer’s sky-high temperatures, worker organizations and others are asking the federal government to take actions to prevent

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.